cart-egfr-il13ra2
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 19, 2023 (NCT05168423)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Epidermal growth factor receptorBINDING AGENT
Epidermal growth factor receptor binding agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07209241 | Phase 1 | Nov 1, 2025 | University of Pennsylvania |
| NCT06973096 | Phase 1 | Jul 18, 2025 | University of Pennsylvania |
| NCT05168423 | Phase 1 | Mar 19, 2023 | Tmunity Therapeutics, University of Pennsylvania |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pennsylvania | Academic/Hospital | 3 | 3 | 1 | 2023 |
| Tmunity Therapeutics | For profit | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1